1Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline membrane disease: bronchopulmonary dysplasia [J]. N Engl J Med, 1967, 276 (7) : 357-368.
2Pusey VA, Maepherson RI, Chemick V. Pulmonary fibroplasia following prolonged artificial ventilation of the newborn infants [J]. Can Med Assoc J, 1969, 100: 451-457
9Bancalari E, del Moral T. Bronchopulmonary dysplasia and surfactant [J]. Biol Neonate, 2001, 80(Suppl 1):7-13.
10Mariani G, Cifuentes J, Carlo WA. Randomized trial of permissive hypercapnia in preterm infants [ J ]. Pediatrics, 1999, 104: 1082-1088.
二级参考文献12
1Bancalari E. Corticosteroids and neonatal chronic lung disease. Eur J Pediatr,1998,157(suppl 1):S31-37.
2Jobe AH,Mitchell BR, Gunkell JH. Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on premature infants. Am J Obstet Gynecol, 1993, 168(2) :508 - 513.
4Fanaroff AA,Stoll BJ,Wright LL Trends in neonatalmorbidity and mortality for very low birthweight infants[J].Am J Obstet Gynecol,2007,196(2):147.
5Moss TJ.Respiratory consequences of preterm birth[J].Clin Exp Pharmacol Physiol,2006,33(3):280.
6Monte LF,Silva Filho LV,Miyoshi MH,et al.Bronchopulmonary dysp lasia[J].J Pediatr,2005,81(2):99.
7Schmidt B,Roberts R,Millar D,et al. Evidence-based neonatal drug therapy for prevention of bronchopulmonary dysplasia in very-low-birth-weight infants[J].Neonatology,2008,93(4):284.
8Grier DG,Hallidy HL Corticosteroids in the prevention and management of bronchopulmonary dysplasia[J].Semin Neonatol,2003,8(1):83.
9Bancalari E,del Moral T.Bronchopulmonary dysplasia and surfactant[J].Biol Neonate,2001,80(Suppl 1):7.
